306 related articles for article (PubMed ID: 34445753)
1. Combination of Drugs and Cell Transplantation: More Beneficial Stem Cell-Based Regenerative Therapies Targeting Neurological Disorders.
Nishimura K; Takata K
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445753
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of stem cells for treatment of neurodegenerative diseases.
Ahmadian-Moghadam H; Sadat-Shirazi MS; Zarrindast MR
Biotechnol Lett; 2020 Jul; 42(7):1073-1101. PubMed ID: 32342435
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of Stem Cells as a Potential Therapeutic Strategy in Neurodegenerative Disorders.
Ebrahimi T; Abasi M; Seifar F; Eyvazi S; Hejazi MS; Tarhriz V; Montazersaheb S
Curr Stem Cell Res Ther; 2021; 16(2):133-144. PubMed ID: 32598273
[TBL] [Abstract][Full Text] [Related]
4. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
5. Novel therapeutic strategies using nanodrug delivery, stem cells and combination therapy for CNS trauma and neurodegenerative disorders.
Sharma HS; Muresanu DF; Sharma A
Expert Rev Neurother; 2013 Oct; 13(10):1085-8. PubMed ID: 24089700
[TBL] [Abstract][Full Text] [Related]
6. Stem cell-based cell therapy in neurological diseases: a review.
Kim SU; de Vellis J
J Neurosci Res; 2009 Aug; 87(10):2183-200. PubMed ID: 19301431
[TBL] [Abstract][Full Text] [Related]
7. Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases.
Lanza V; Milardi D; Di Natale G; Pappalardo G
Curr Med Chem; 2018 Feb; 25(4):525-539. PubMed ID: 28521682
[TBL] [Abstract][Full Text] [Related]
8. Repackaging FDA-approved drugs for degenerative diseases: promises and challenges.
Cummings JL; Zhong K
Expert Rev Clin Pharmacol; 2014 Mar; 7(2):161-5. PubMed ID: 24502586
[TBL] [Abstract][Full Text] [Related]
9. Neural stem cell-based treatment for neurodegenerative diseases.
Kim SU; Lee HJ; Kim YB
Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Role of Stem Cell Therapy in Treating Neurodegenerative Diseases: Challenges and Current Perspectives.
Puranik N; Arukha AP; Yadav SK; Yadav D; Jin JO
Curr Stem Cell Res Ther; 2022; 17(2):113-125. PubMed ID: 35135462
[TBL] [Abstract][Full Text] [Related]
11. Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation.
Arbo BD; Schimith LE; Goulart Dos Santos M; Hort MA
Eur J Pharmacol; 2022 Mar; 919():174800. PubMed ID: 35131314
[TBL] [Abstract][Full Text] [Related]
12. Repurposing small-molecule drugs for modulating toxic protein aggregates in neurodegenerative diseases.
Liu W; Wang G; Wang Z; Wang G; Huang J; Liu B
Drug Discov Today; 2022 Jul; 27(7):1994-2007. PubMed ID: 35395400
[TBL] [Abstract][Full Text] [Related]
13. Insights into Computational Drug Repurposing for Neurodegenerative Disease.
Paranjpe MD; Taubes A; Sirota M
Trends Pharmacol Sci; 2019 Aug; 40(8):565-576. PubMed ID: 31326236
[TBL] [Abstract][Full Text] [Related]
14. Regenerative cellular therapies for neurologic diseases.
Levy M; Boulis N; Rao M; Svendsen CN
Brain Res; 2016 May; 1638(Pt A):88-96. PubMed ID: 26239912
[TBL] [Abstract][Full Text] [Related]
15. Organotypic cultures as tools for optimizing central nervous system cell therapies.
Daviaud N; Garbayo E; Schiller PC; Perez-Pinzon M; Montero-Menei CN
Exp Neurol; 2013 Oct; 248():429-40. PubMed ID: 23899655
[TBL] [Abstract][Full Text] [Related]
16. New therapeutic strategy for Parkinson's and Alzheimer's disease.
Esposito E; Cuzzocrea S
Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
[TBL] [Abstract][Full Text] [Related]
17. Current Perspective of Stem Cell Therapy in Neurodegenerative and Metabolic Diseases.
Kumar A; Narayanan K; Chaudhary RK; Mishra S; Kumar S; Vinoth KJ; Padmanabhan P; Gulyás B
Mol Neurobiol; 2017 Nov; 54(9):7276-7296. PubMed ID: 27815831
[TBL] [Abstract][Full Text] [Related]
18. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
[TBL] [Abstract][Full Text] [Related]
19. Pluripotent stem cell strategies for rebuilding the human brain.
Limone F; Klim JR; Mordes DA
Front Aging Neurosci; 2022; 14():1017299. PubMed ID: 36408113
[TBL] [Abstract][Full Text] [Related]
20. Human Pluripotent Stem Cells-Based Therapies for Neurodegenerative Diseases: Current Status and Challenges.
Ford E; Pearlman J; Ruan T; Manion J; Waller M; Neely GG; Caron L
Cells; 2020 Nov; 9(11):. PubMed ID: 33233861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
